Intensive chemotherapy of poor prognosis myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS with idarubicin and cytarabine (Q73251586)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 February 1997

Language	Label	Description	Also known as
English	Intensive chemotherapy of poor prognosis myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS with idarubicin and cytarabine	scientific article published on 01 February 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Intensive chemotherapy of poor prognosis myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS with idarubicin and cytarabine (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

T Ruutu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Hänninen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Järventie

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Koistinen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E Koivunen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Kätkä

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Nousiainen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Oksanen

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T T Pelliniemi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Remes

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Timonen

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

E Elonen

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 February 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Leukemia Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

133-138

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Intensive chemotherapy in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of intensive chemotherapy in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive Chemotherapy and Bone Marrow Transplantation for Myelodysplastic Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of idarubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of idarubicinol on the antileukemic effect of idarubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular effects of doxorubicin (Adriamycin) and 4-demethoxydaunorubicin (Idarubicin) in the conscious rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of myelodysplastic syndromes with AML-type chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

New treatment approaches for myelodysplastic syndrome and secondary leukaemias

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation for myelodysplastic syndrome and secondary leukaemias

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2896%2900116-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0145-2126(96)00116-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9112430%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73251586&oldid=1832063436"